Literature DB >> 1269214

A completely absorbed oral preparation of digoxin.

B F Johnson, C Bye, G Jones, G A Sabey.   

Abstract

Digoxin absorption was studied in healthy volunteers by determination of peak plasma concentrations, areas under plasma concentration curves, and urinary excretion after single-dose administration. By comparison with an aqueous solution, increased rate and extent of absorption occurred from experimental soft gelatin formulations of digoxin in solution. Enhanced bioavailability of the capsules was not affected by altered volume of contained solvent. Digoxin was considerably better absorbed from capsules than from tablets of moderately high dissolution rate. Mean percentage intestinal absorption was 75% from tablet and 97% from capsules. Reduced between-subject variability accompanied the enhanced absorption from capsules.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269214     DOI: 10.1002/cpt1976196746

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.

Authors:  J G Wagner; R G Stoll; D J Weidler; J W Ayres; M R Hallmark; E Sakmar; A Yacobi
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

2.  Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.

Authors:  J G Wagner; J W Ayres
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 3.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

4.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

5.  Drug interactions with digoxin.

Authors:  D D Brown; R Spector; R P Juhl
Journal:  Drugs       Date:  1980-09       Impact factor: 9.546

6.  Michaelis-Menten absorption kinetics in drugs: - examples and implications.

Authors:  J H Wood; K M Thakker
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Influence of soft gelatin on digoxin absorption.

Authors:  J O'Grady; B F Johnson; C Bye; G A Sabey
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

8.  The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.

Authors:  B F Johnson; G Smith; J French
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

9.  The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.

Authors:  J O'Grady; B F Johnson; C Bye; J French
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

10.  The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.

Authors:  A F Cohen; R Kroon; H C Schoemaker; D D Breimer; A Van Vliet-Verbeek; H C Brandenburg
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.